//
Sex Differences in Heart Failure With Preserved Ejection Fraction Pathophysiology: A Detailed Invasive Hemodynamic and Echocardiographic Analysis
Clinical Phenogroups in Heart Failure With Preserved Ejection Fraction: Detailed Phenotypes, Prognosis, and Response to Spironolactone
Respiratory Syncytial Virus and Associations With Cardiovascular Disease in Adults
Risk of Mortality Following Catheter Ablation of Atrial Fibrillation
SPECT and PET in ischemic heart failure
Atrial Fibrillation and the Prognostic Performance of Biomarkers in Heart Failure
Prior Pacemaker Implantation and Clinical Outcomes in Patients With Heart Failure and Preserved Ejection Fraction
A trial to evaluate the effect of the sodium-glucose co-transporter 2 inhibitor dapagliflozin on morbidity and mortality in patients with heart failure and reduced left ventricular ejection fraction (DAPA-HF)